Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

about

Cancer vaccine strategies: translation from mice to human clinical trials.Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels.White paper on microbial anti-cancer therapy and prevention

P2860

Q48295639-1FCDE1F8-9D6D-4D27-8A3A-F8288AD2D498 Q51766347-A6029240-842E-437C-866C-88BEE67720A8 Q56898750-EA1EB798-4DE9-4EE6-B507-570EDECB6A2A

P2860

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

Item

http://www.wikidata.org/entity/Q38600417

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

@en

type

Item

label

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

@en

prefLabel

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

@en

P1476

Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations

@en

P2093

Jason M Redman

http://www.w3.org/2001/XMLSchema#string

Julie M Collins

http://www.w3.org/2001/XMLSchema#string

Margaret E Gatti-Mays

http://www.w3.org/2001/XMLSchema#string

P2860

IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment

Cancer vaccines: are we there yet?

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

The blockade of immune checkpoints in cancer immunotherapy

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma

The interplay of immunotherapy and chemotherapy: harnessing potential synergies

P304

2561-2574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1364322

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marijo Bilusic

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28857666

http://www.w3.org/2001/XMLSchema#string

P932

5703410

http://www.w3.org/2001/XMLSchema#string

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

about

P2860

P2860

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932